Why these ASX cannabis shares are on the move today

BOD Australia Ltd (ASX:BDA), Creso Pharma Limited (ASX:CPH), and MGC Pharmaceuticals Ltd (ASX:MXC) shares are on watch today after making announcements…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a busy day in the Australian cannabis industry with a series of an announcements being made this morning.

Here's what has been happening today:

BOD Australia Ltd (ASX: BDA)

This morning this medicinal cannabis healthcare products company revealed solid medicinal cannabis prescription growth throughout September for its MediCabilis CBD product. According to the release, Bod dispensed 549 MediCabilis prescriptions in September, which was a 67% increase on the 329 prescriptions it reported in August. CEO Jo Patterson said: "The ongoing growth that Bod is witnessing in medicinal cannabis prescriptions highlights not only the versatility of our MediCabilis product, but also the outstanding quality of our extract. The repeat prescriptions which are underpinning growth also shows that there is considerable satisfaction from patients and also confidence in the product in the medical community."

Creso Pharma Limited (ASX: CPH)

This cannabis company provided an update on the status of its proposed acquisition by PharmaCielo by way of schemes of arrangement. According to the release, the Supreme Court of Western Australia has made orders that the company convene a meeting of its shareholders to consider and vote on the share scheme. Shareholders will be invited to vote on the takeover by PharmaCielo on November 11 in Perth. The Creso Pharma board continues to unanimously recommend that shareholders vote in favour of the proposed schemes, in the absence of a superior proposal.

MGC Pharmaceuticals Ltd (ASX: MXC)

Also releasing an announcement this morning was this European based cannabis company. It announced that the number of patients which are being prescribed its standardised, affordable cannabinoid medicines have passed the 400-prescription mark. This doubles the number of prescriptions since its 200 milestone which was announced in mid-September. Management explained that the increase demonstrated patient interest and demand for its phytocannabinoid derived medicines, the quality and cost competitiveness of its medicines, and its increasing distribution rollout capabilities.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why did this top broker just downgrade DroneShield shares?

The broker believes its shares are fully valued at current levels.

Read more »

A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently
Broker Notes

Woolworths shares 'less placed' says top broker

Could the supermarket giant's share price be under pressure?

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Tuesday

The Australian share market is expected to return to form today.

Read more »

Man on a laptop thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield-eque start to the trading week this Monday.

Read more »

A young boy with a sombre face looks down at the zip fastener at the bottom of his jacket as he concentrates on unfastening the clasp.
BNPL shares

What's happening with Zip shares on their first day back aboard the ASX 200?

After a strong eight month run, Zip shares are once again part of the ASX 200.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Healthcare Shares

If you invested $5,000 in this ASX pharmaceuticals stock a year ago, you'd have $34,711 now!

Just how lucky have investors been with this stock?

Read more »

A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
Share Gainers

Why these 2 ASX 200 shares are surging amid today's market meltdown

Investors are bidding up these two ASX 200 shares despite the wider market meltdown. But why?

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Share Gainers

Why 29Metals, Immutep, Insignia, and Perenti shares are pushing higher today

These shares are avoiding the market selloff. But why?

Read more »